FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

137 hedge funds and large institutions have $88.8M invested in Fate Therapeutics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+7
Holders Change %
+5.38%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
45
Reduced
40
Closed
21
Calls
$264K
Puts
$40K
Net Calls
+$224K
Net Calls Change
+$166K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$633K
2
Jane Street
Jane Street
New York
+$450K
3
AQR Capital Management
AQR Capital Management
Connecticut
+$293K
4
GCP
GSA Capital Partners
United Kingdom
+$288K
5
Citadel Advisors
Citadel Advisors
Florida
+$285K

Top Sellers

1
SSA
Schonfeld Strategic Advisors
New York
-$7.69M
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$3.74M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.73M
4
O
OrbiMed
New York
-$1.33M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.11M
Name Holding Trade Value Shares
Change 		Shares
Change %
PMAM
151
Picton Mahoney Asset Management
Ontario, Canada
– -$4K -5,369 Closed
WA
152
Wilshire Advisors
California
– -$13.2K -4,083 Closed
CCM
153
Coldstream Capital Management
Washington
– -$542 -686 Closed
CA
154
CoreCap Advisors
Michigan
– -$201 -255 Closed
LWMI
155
Legacy Wealth Management (Idaho)
Idaho
– -$91 -115 Closed
RIL
156
Rothschild Investment LLC
Illinois
– -$55 -70 Closed
3 4 5 6
7